EW Edwards Lifesciences Corporation Common Stock
NYSE · Health Care · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 4, 2026
$85.15
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$72.3052w निम्न
$96.2952w उच्च
मार्केट कैप (MRQ)
$49.10B
P/E (TTM)
48.9
EPS (TTM)
$1.74
राजस्व (TTM)
$6.51B
आपके बैज
52W रेंज
$72–$96
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$101
P/E
48.9
ROE
9.5%
शुद्ध लाभ मार्जिन
15.4%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
EW स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$85.15
मार्केट कैप (MRQ)
$49.10B
P/E (TTM)
48.9
EPS (TTM)
$1.74
राजस्व (TTM)
$6.51B
ROE (TTM)
9.5%
D/E ऋण/इक्विटी (MRQ)
0.1
52W रेंज
$72–$96
EW स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
स्टॉक विभाजन
| एक्स-डेट | स्प्लिट | प्रकार |
|---|---|---|
| 1 जून 2020 | 3-for-1 | फॉरवर्ड |
| 14 दिसमबर 2015 | 2-for-1 | फॉरवर्ड |
| 28 मई 2010 | 2-for-1 | फॉरवर्ड |
Edwards Lifesciences Corporation Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.
History
Edwards Lifesciences was originally founded by electrical engineer Miles "Lowell" Edwards in 1958, a graduate of Oregon State University. Edwards invented the first medically proven and adopted artificial heart valve. Dr. Albert Starr, a surgeon at the Oregon Health and Sciences University, is credited as the first to successfully implant the Starr-Edwards mitral valve in a patient in 1960. As a result of the successful heart implant, Edwards established manufacturing in Santa Ana, California the same year to continue his research in pulmonary devices.
Edwards' valves are still in operation today. An early patient lived a record 48 years with the implant before requiring a replacement.
Edwards was acquired by Baxter in 1985. It was spun off from Baxter in 2000.
In 2017, Edwards completed the acquisition of Valtech Cardio for $340 million. Also in 2017, Edwards acquired Harpoon Medical of Baltimore, Maryland for $100 million. Harpoon, founded in 2013, developed a minimally invasive heart surgery product for mitral valve repair to treat degenerative mitral regurgitation. At the time of the acquisition, the product was not available on any market.
On April 18, 2019, Edwards completed the acquisition of CAS Medical Systems of Branford, Connecticut for ~$100 million.
Edwards Sapien 3 and Sapien 3 Ultra Transcatheter Heart Valve systems were FDA-approved for the treatment of patients at low risk for death or major complications associated with open-heart surgery on August 16, 2019. These products are used to treat patients with severe aortic stenosis without utilizing open-heart surgery.
In 2020, Edwards co-sponsored the Virtual ISPOR-FDA Summit centered on patient preference information in medical device regulatory decisions.
In December 2021, the FDA approved the SAPIEN 3 transcatheter valve in combination with the Alterra adaptive prestent for the treatment of severe pulmonary regurgitation.
In February 2024, the FDA approved Edwards' EVOQUE tricuspid valve replacement system, the first transcatheter therapy approved in the United States for the treatment of tricuspid regurgitation. In May 2024, Edwards launched the SAPIEN 3 Ultra RESILIA valve in Europe.
In June 2024, the company received FDA approval for a new implant designed to manage heart failure issues, called the Cordella pulmonary artery sensor.
In July 2024, Edwards made agreements with Affluent Medical for an equity stake, IP licensing and an exclusive option to acquire its Kephalios subsidiary. The same month, Edwards announced it would acquire Innovalve Bio Medical for approximately $300 million, and JenaValve Technology and Endotronix for $1.2 billion.
In August 2024, Edwards acquired JC Medical from Genesis MedTech, gaining its J-Valve transcatheter aortic valve replacement system for the treatment of aortic regurgitation.
In 2023, Edwards announced that its critical care business unit would be spun off into a separate entity. In June 2024 Edwards instead agreed to sell the unit to BD for $4.2 billion. The sale closed on September 3, 2024.
In May 2025, the FDA approved the SAPIEN 3 platform, including the SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA valves, for the treatment of severe aortic stenosis in asymptomatic patients, marking the first FDA approval of TAVR therapy for this patient population.
In September 2025, Edwards completed the full acquisition of heart failure monitoring company Vectorious Medical Technologies.
In January 2026, the FDA approved the SAPIEN M3 mitral valve replacement system, the first transcatheter mitral valve replacement therapy using a transseptal approach to receive FDA approval for the treatment of mitral regurgitation.
Business segments
Prior to September 2024, its products were categorized into four areas: surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and critical care. In September 2024, Edwards completed the sale of its Critical Care product group to BD. Since September 2024, its products are categorized into four areas: surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and implantable heart failure management (IHFM).
Transcatheter Heart Valve
The company's SAPIEN family of transcatheter aortic heart valves is made of bovine pericardial tissue mounted within a balloon-expandable, cobalt-chromium frame and is deployed via catheter. Edwards introduced the transcatheter heart valve replacement procedure to U.S. patients unable to undergo open-heart surgery with FDA approval of the SAPIEN transcatheter valve in 2011. The indication was expanded in November 2012 to include patients at a high risk for death or serious complications associated with open-heart surgery. In 2021, the FDA cleared Edwards’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement. In May 2024, Edwards launched the SAPIEN 3 Ultra RESILIA valve in Europe.
Transcatheter Mitral and Tricuspid Therapies
The Transcatheter Mitral and Tricuspid Therapies business segment develops transcatheter heart valve repair and replacement technologies to treat mitral and tricuspid valve diseases. In September 2022, the FDA approved Edwards' PASCAL Precision transcatheter valve repair system for the treatment of degenerative mitral regurgitation.
Surgical
The Surgical business segment involves the use of Edwards' RESILIA tissue technology, developed to help limit valve calcification. Edwards estimates that more than 450,000 patients around the world have either undergone SAVR or TAVR with an Edwards RESILIA valve.
Critical Care
Before its sale, the Critical Care business segment included pulmonary artery catheters, disposable pressure transducers and advanced hemodynamic monitoring systems. The portfolio also included a line of balloon catheter-based vascular products, surgical clips and inserts. In 2023, it was announced that the critical care business unit was to be spun off into its own entity, however in 2024 the critical care department was purchased by BD for $4.2 billion.
Organizational culture
Edwards Lifesciences Foundation
The Edwards Lifesciences Foundation launched in 2014 and supports programs designed to treat underserved people to reduce heart valve disease.
Since the initiative launched in 2014, Edwards and its foundation have contributed more than $100 million in financial and technology donations through "Every Heartbeat Matters" (EHM), reaching over 4 million underserved structural heart patients globally.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealth Care
उद्योगHealth Care
कर्मचारी16000
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$6.07B2016-12-31 → 2025-12-31
EPS$1.832016-12-31 → 2025-12-31
फ्री कैश फ्लो$1.33B2016-12-31 → 2025-12-31
शुद्ध मार्जिन15.4%2023-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | EW | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | 48.95Y औसत ≈35.1 | ≈35.1 | 31.0 | अति मूल्यांकित | |
| P/S (TTM) | 7.55Y औसत ≈10.2 | ≈10.2 | 5.0 | अति मूल्यांकित | |
| P/B (MRQ) | 4.65Y औसत ≈7.5 | ≈7.5 | 5.0 | उचित मूल्य | |
| EV / EBITDA (TTM) | 28.15Y औसत ≈30.5 | ≈30.5 | 27.0 | अति मूल्यांकित | |
| मूल्य / FCF (TTM) | 34.25Y औसत ≈72.6 | ≈72.6 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | 28.55Y औसत ≈49.3 | ≈49.3 | 26.4 | अति मूल्यांकित | |
| EV / राजस्व (TTM) | 7.05Y औसत ≈9.8 | ≈9.8 | · | · | |
| EV / FCF (TTM) | 31.75Y औसत ≈69.1 | ≈69.1 | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | 5.35Y औसत ≈10.1 | ≈10.1 | · | · | |
| PEG Ratio (PEG अनुपात) | ≈6.9 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | EW | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| सकल मार्जिन (TTM) | 77.8%5Y औसत ≈78.1% | ≈78.1% | 65.9% | शीर्ष स्तर | |
| परिचालन मार्जिन (TTM) | 22.3%5Y औसत ≈27.3% | ≈27.3% | 24.8% | शीर्ष स्तर | |
| EBITDA मार्जिन (TTM) | 24.8%5Y औसत ≈29.9% | ≈29.9% | 29.5% | अनुरूप | |
| प्रीटैक्स मार्जिन (TTM) | 21.8%5Y औसत ≈28.3% | ≈28.3% | 24.0% | शीर्ष स्तर | |
| शुद्ध लाभ मार्जिन (TTM) | 15.4%5Y औसत ≈39.3% | ≈39.3% | 17.8% | कमजोर | |
| ROA (TTM) | 7.3%5Y औसत ≈20.4% | ≈20.4% | 7.9% | अनुरूप | |
| ROE (TTM) | 9.5%5Y औसत ≈27.7% | ≈27.7% | 15.9% | कमजोर | |
| ROIC | 9.6%5Y औसत ≈17.3% | ≈17.3% | 11.5% | कमजोर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | EW | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | 0.15Y औसत ≈0.1 | ≈0.1 | 0.6 | कम ऋण | |
| वर्तमान अनुपात (MRQ) | 4.55Y औसत ≈3.5 | ≈3.5 | 1.6 | मजबूत तरलता | |
| त्वरित अनुपात (MRQ) | 3.35Y औसत ≈2.3 | ≈2.3 | 0.9 | मजबूत तरलता | |
| दीर्घकालिक ऋण / इक्विटी (MRQ) | 0.15Y औसत ≈0.1 | ≈0.1 | 0.6 | कम ऋण |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | EW | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 11.6%5Y औसत ≈7.4% | ≈7.4% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 10.8%5Y औसत ≈5.5% | ≈5.5% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 6.7% | · | · | · | |
| EPS YoY | -73.7%5Y औसत ≈41.8% | ≈41.8% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | -74.3%5Y औसत ≈29.2% | ≈29.2% | · | · | |
| EPS CAGR 3Y | -9.1%5Y औसत ≈18.3% | ≈18.3% | · | · | |
| EPS CAGR 5Y | 7.1% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | -11.0% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | EW | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.55Y औसत ≈0.6 | ≈0.6 | 0.5 | कमजोर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 1.25Y औसत ≈1.3 | ≈1.3 | 2.4 | कमजोर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 9.65Y औसत ≈8.8 | ≈8.8 | 6.8 | शीर्ष स्तर | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$379.2K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
2.6%
अगली रिपोर्ट
अक्ट 28, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | जुल 22, 2026 | $0.78 | $0.76 | 2.3% |
| 31 मार्च 2026 | $0.78 | $0.75 | 4.2% | |
| 31 दिसमबर 2025 | $0.58 | $0.64 | -8.8% | |
| 30 सितमबर 2025 | $0.67 | $0.61 | 9.6% | |
| 30 जून 2025 | $0.67 | $0.64 | 4.4% | |
| 31 मार्च 2025 | $0.64 | $0.61 | 4.1% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B | $4.35B | $3.72B | $3.44B | $2.96B | $2.49B | $2.32B | |
| Cost of Revenue | $1.33B | $1.12B | $978M | $724M | $1.25B | $1.08B | $1.11B | $939M | $875M | $797M | $617M | $626M | |
| Gross Profit | $4.73B | $4.32B | $4.03B | $3.74B | $3.98B | $3.31B | $3.23B | $2.78B | $2.56B | $2.17B | $1.88B | $1.70B | |
| R&D Expense | $1.08B | $1.05B | $963M | $844M | $903M | $761M | $753M | $622M | $553M | $442M | $383M | $346M | |
| SG&A Expense | $2.09B | $1.79B | $1.58B | $1.36B | $1.49B | $1.23B | $1.24B | $1.09B | $991M | $905M | $851M | $858M | |
| Operating Income | $1.26B | $1.38B | $1.31B | $1.50B | $1.69B | $898M | $1.15B | $748M | $1.09B | $751M | · | · | |
| Interest Expense | · | · | $18M | $19M | $18M | $16M | $21M | $30M | $23M | $19M | $17M | $17M | |
| Interest Income | $169M | $120M | $67M | $36M | $17M | $23M | $32M | $32M | $20M | $11M | $8M | $6M | |
| Other Non-op | $7M | $69M | $14M | $5M | $13M | $12M | $8M | $4M | $-1M | $-5M | $-4M | $-8M | |
| Pretax Income | $1.27B | $1.55B | $1.37B | $1.52B | $1.70B | $917M | $1.17B | $761M | $1.03B | $738M | $622M | $1.14B | |
| Income Tax | $217M | $152M | $152M | $196M | $199M | $93M | $120M | $39M | $451M | $168M | $128M | $333M | |
| Net Income | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | · | · | · | · | · | · | · | |
| EPS (Basic) | $1.84 | $6.98 | $2.31 | $2.46 | $2.41 | $1.32 | $1.68 | $1.15 | $2.77 | $2.67 | $2.30 | $3.81 | |
| EPS (Diluted) | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 | $1.30 | $1.64 | $1.13 | $2.70 | $2.61 | $2.25 | $3.74 | |
| Shares (Basic) | 584,800,000 | 597,700,000 | 606,700,000 | 619,000,000 | 623,300,000 | 622,600,000 | 624,800,000 | 627,600,000 | 210,900,000 | 213,000,000 | 215,500,000 | 213,000,000 | |
| Shares (Diluted) | 585,800,000 | 599,300,000 | 609,400,000 | 624,200,000 | 631,200,000 | 631,900,000 | 636,700,000 | 640,900,000 | 215,900,000 | 217,800,000 | 220,300,000 | 217,000,000 | |
| EBITDA | $1.42B | $1.53B | $1.68B | $1.89B | $1.83B | $1.00B | $1.24B | $826M | $82M | $71M | $66M | $69M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.94B | $3.05B | $1.13B | $769M | $863M | $1.18B | $1.18B | $714M | $818M | $930M | $718M | $654M | |
| Short-term Investments | $1.29B | $931M | $500M | $446M | $604M | $219M | $338M | $242M | $519M | $341M | $506M | $785M | |
| Receivables | $660M | $609M | $772M | $643M | $582M | $515M | $544M | $457M | $439M | $366M | $315M | $288M | |
| Inventory | $1.13B | $1.09B | $904M | $876M | $727M | $802M | $641M | $607M | $555M | $397M | $340M | $297M | |
| Prepaid Expense | $135M | $121M | $129M | $110M | $85M | $75M | $59M | $54M | $61M | $46M | $45M | $49M | |
| Other Current Assets | $339M | $348M | $225M | $196M | $237M | $208M | $168M | $132M | $117M | $112M | $66M | $122M | |
| Current Assets | $6.74B | $6.29B | $4.04B | $3.10B | $3.18B | $3.09B | $2.98B | $2.29B | $2.55B | $2.24B | $2.05B | $2.23B | |
| PP&E (Net) | $1.81B | $1.69B | $1.59B | $1.63B | $1.55B | $1.40B | $1.06B | $868M | $680M | $580M | $482M | $443M | |
| PP&E (Gross) | $2.66B | $2.48B | $2.29B | $2.38B | $2.20B | $1.99B | $1.57B | $1.32B | $1.09B | $961M | $854M | $808M | |
| Accum. Depreciation | $850M | $794M | $699M | $750M | $655M | $598M | $512M | $455M | $412M | $381M | $372M | $365M | |
| Goodwill | $1.77B | $1.78B | $1.15B | $1.06B | $1.17B | $1.17B | $1.17B | $1.11B | $1.13B | $626M | $628M | $376M | |
| Intangibles | $1.13B | $1.18B | $399M | $285M | $324M | $331M | $336M | $343M | $468M | $205M | $205M | $23M | |
| Other Non-current Assets | $730M | $722M | $463M | $299M | $111M | $120M | $102M | $34M | $109M | $123M | $132M | $49M | |
| Total Assets | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B | $6.49B | $5.32B | $5.67B | $4.51B | $4.06B | $3.52B | |
| Accounts Payable | $228M | $197M | $187M | $202M | $204M | $196M | $180M | $134M | $117M | $97M | $64M | $58M | |
| Current Liabilities | $1.81B | $1.51B | $1.20B | $1.02B | $1.03B | $894M | $902M | $877M | $1.42B | $532M | $476M | $426M | |
| Capital Leases | $83M | $79M | $65M | $70M | $69M | $73M | $59M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $37M | · | · | · | · | · | |
| Other Non-current Liabilities | $362M | $373M | $251M | $218M | $267M | $252M | $203M | $150M | $147M | $115M | $285M | $113M | |
| Total Liabilities | $3.36B | $2.99B | $2.64B | $2.49B | $2.67B | $2.66B | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | $594M | $1.04B | $822M | · | · | |
| Total Debt | $598M | $598M | $597M | $596M | $596M | $595M | $594M | $594M | $1.04B | $822M | $600M | $598M | |
| Common Stock | $659M | $655M | $650M | $646M | $642M | $636M | $218M | $215M | $212M | $243M | $239M | $129M | |
| Retained Earnings | $14.24B | $13.17B | $8.99B | $7.59B | $6.07B | $4.57B | $3.74B | $2.69B | $1.96B | $3.91B | $3.34B | $2.84B | |
| Treasury Stock | $7.09B | $6.19B | $5.02B | $4.14B | $2.42B | $1.90B | $1.28B | $1.02B | $252M | $2.50B | $1.84B | $1.56B | |
| AOCI | $-238M | $-244M | $-243M | $-255M | $-158M | $-161M | $-156M | $-138M | $-133M | $-198M | $-183M | $-101M | |
| Stockholders' Equity | $10.34B | $10.00B | $6.65B | $5.81B | $5.84B | $4.57B | $4.15B | $3.14B | $2.96B | $2.62B | $2.50B | $2.19B | |
| Liabilities + Equity | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B | $6.49B | $5.32B | $5.67B | $4.51B | $4.06B | $3.52B | |
| Shares Outstanding | 580,700,000 | 654,800,000 | 650,500,000 | 646,300,000 | 642,000,000 | 636,400,000 | 218,100,000 | 207,700,000 | 209,700,000 | 211,600,000 | 215,400,000 | 107,800,000 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $157M | $155M | $145M | $140M | $135M | $107M | $89M | $77M | $82M | $71M | $66M | $69M | |
| Stock-based Comp | $158M | $162M | $139M | $127M | $109M | $93M | $81M | $71M | $62M | $57M | $50M | $48M | |
| Deferred Tax | $-66M | $-163M | $-242M | $-262M | $-44M | $-52M | $10M | $-21M | $27M | $-24M | $-16M | $-67M | |
| Amort. of Intangibles | $8M | $6M | $2M | $2M | $8M | $5M | $5M | $2M | $8M | $8M | $7M | $8M | |
| Restructuring | $13M | $33M | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-cash | $273M | $-3.79B | $-529M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $1.60B | $542M | $896M | $1.22B | $1.73B | $1.05B | $1.18B | $927M | $1.00B | $704M | $550M | $1.02B | |
| CapEx | $260M | $252M | $253M | $245M | $326M | $407M | $254M | $239M | $168M | $176M | $103M | $83M | |
| Investing Cash Flow | $-713M | $2.31B | $174M | $252M | $-1.72B | $-531M | $-596M | $77M | $-647M | $-212M | $-316M | · | |
| Debt Issued | · | · | $0 | $0 | $5M | $16M | $19M | $688M | $995M | $254M | $31M | $226M | |
| Net Debt Issued | · | · | $0 | $0 | $5M | $16M | $19M | $688M | $995M | $254M | $31M | $226M | |
| Stock Repurchased | $893M | $1.16B | $880M | $1.73B | $513M | $625M | $263M | $796M | $763M | $662M | $280M | $301M | |
| Net Stock Activity | $-893M | $-1.16B | $-880M | $-1.73B | $-513M | $-625M | $-263M | $-796M | $-763M | $-662M | $-280M | $-301M | |
| Financing Cash Flow | $-957M | $-983M | $-711M | $-1.58B | $-356M | $-487M | $-116M | $-1.10B | $-473M | $-268M | $-159M | · | |
| Net Change in Cash | $-119M | $1.91B | $375M | $-95M | $-333M | $16M | $468M | $-104M | $-112M | $212M | $65M | $233M | |
| Taxes Paid | $490M | $1.20B | $470M | · | · | · | · | · | · | · | · | $275M | |
| Free Cash Flow | $1.33B | $290M | $643M | $974M | $1.41B | $647M | $925M | $688M | $833M | $528M | $447M | $939M | |
| Levered FCF | · | · | $627M | $957M | $1.39B | $633M | $906M | $660M | $820M | $513M | $433M | $927M |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.0% | 79.5% | 77.0% | 79.9% | 76.1% | 75.4% | 74.4% | 74.8% | 74.5% | 73.1% | 75.2% | 73.1% | |
| Operating Margin | 20.8% | 25.4% | 25.6% | 32.5% | 32.3% | 20.5% | 26.4% | 20.1% | · | · | · | · | |
| Net Margin | 17.7% | 76.8% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | 21.0% | 28.5% | 26.6% | 32.8% | 32.5% | 20.9% | 26.8% | 20.4% | 30.1% | 24.9% | 25.0% | 49.2% | |
| EBITDA Margin | 23.4% | 28.2% | 28.0% | 35.1% | 34.9% | 22.9% | 28.4% | 22.2% | 2.4% | 2.4% | 2.6% | 2.9% | |
| ROA | 8.0% | 37.2% | 15.9% | · | · | · | · | · | · | · | · | · | |
| ROE | 10.6% | 50.1% | 22.5% | · | · | · | · | · | · | · | · | · | |
| ROIC | 9.6% | 11.7% | 18.5% | 23.5% | 23.2% | 15.6% | 21.7% | 19.0% | · | · | · | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.2 | 3.4 | 3.0 | 3.1 | 3.5 | 3.3 | 2.6 | 1.8 | 4.2 | 4.3 | 5.3 | |
| Quick Ratio | 2.7 | 3.0 | 2.0 | 1.8 | 2.0 | 2.1 | 2.3 | 1.6 | 1.3 | 3.1 | 3.2 | 4.0 | |
| Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.3 | 0.2 | 0.3 | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.3 | 0.2 | 0.3 | |
| Interest Coverage | · | · | 87.2 | 91.1 | 91.9 | 56.8 | 55.4 | 25.0 | · | · | · | · |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.7 | 0.6 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Inventory Turnover | 1.2 | 1.1 | 1.4 | 1.3 | 1.6 | 1.5 | 1.8 | 1.6 | 1.8 | 2.2 | 1.9 | 2.1 | |
| Receivables Turnover | 9.6 | 7.9 | 8.5 | 8.8 | 9.5 | 8.3 | 8.7 | 8.3 | 8.7 | 8.7 | 8.3 | 7.9 |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.80 | $16.99 | $11.06 | $9.55 | $9.35 | $7.33 | $19.84 | $15.12 | $14.10 | $12.38 | $11.62 | $20.33 | |
| Revenue / Share | $10.36 | $9.08 | $9.85 | $8.62 | $8.29 | $6.94 | $20.49 | $17.43 | $15.91 | $13.61 | $11.32 | $21.41 | |
| Cash Flow / Share | $2.72 | $0.90 | $1.47 | $1.95 | $2.74 | $1.67 | $5.56 | $4.34 | $4.63 | $3.23 | $2.50 | $9.42 | |
| Cash / Share | $5.06 | $5.17 | $1.90 | $1.26 | $1.38 | $1.90 | $5.64 | $3.44 | $3.90 | $4.40 | $3.34 | $6.06 | |
| EPS (TTM) | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 | $1.30 | $1.64 | $1.13 | $2.70 | $2.61 | $2.25 | $3.74 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.6% | 8.6% | 12.2% | -14.7% | 19.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.8% | 1.3% | 4.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -73.7% | 203.0% | -5.7% | 2.5% | 83.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -9.1% | 43.1% | 20.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -74.3% | 197.7% | -7.8% | 1.2% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -11.0% | 40.6% | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B | $4.35B | $3.72B | $3.44B | $2.96B | $2.49B | $2.32B | |
| Net Income TTM | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | $235M | $235M | $235M | $235M | $235M | $235M | $235M | |
| Market Cap | $49.50B | $43.57B | $45.83B | $45.39B | $80.85B | $56.95B | $16.26B | $10.60B | $7.88B | $6.61B | $5.67B | $2.29B | |
| Enterprise Value | $45.88B | $40.20B | $44.79B | $44.77B | $79.98B | $56.15B | $15.34B | $10.24B | $7.58B | $6.16B | $5.05B | $1.45B | |
| P/E | 46.6 | 10.6 | 33.2 | 30.6 | 54.4 | 70.2 | 47.4 | 45.2 | 13.9 | 12.0 | 11.7 | 5.7 | |
| P/S | 8.2 | 8.0 | 9.1 | 10.2 | 15.5 | 13.0 | 3.7 | 2.8 | 2.3 | 2.2 | 2.3 | 1.0 | |
| P/B | 4.8 | 4.4 | 6.9 | 7.8 | 13.9 | 12.5 | 3.9 | 3.4 | 2.7 | 2.5 | 2.3 | 1.0 | |
| P / Tangible Book | 6.7 | 6.2 | 9.0 | 10.2 | 18.6 | 18.6 | · | · | · | · | · | · | |
| P / Cash Flow | 31.0 | 80.4 | 51.2 | 37.3 | 46.7 | 54.0 | 13.8 | 11.4 | 7.9 | 9.4 | 10.3 | 2.2 | |
| P / FCF | 37.1 | 150.3 | 71.3 | 46.6 | 57.5 | 88.0 | 17.6 | 15.4 | 9.5 | 12.5 | 12.7 | 2.4 | |
| EV / EBITDA | 32.3 | 26.2 | 26.7 | 23.7 | 43.8 | 55.9 | 12.4 | 12.4 | 92.5 | 86.5 | 76.7 | 21.1 | |
| EV / FCF | 34.4 | 138.7 | 69.7 | 46.0 | 56.9 | 86.7 | 16.6 | 14.9 | 9.1 | 11.7 | 11.3 | 1.5 | |
| EV / Revenue | 7.6 | 7.4 | 8.9 | 10.0 | 15.3 | 12.8 | 3.5 | 2.8 | 2.2 | 2.1 | 2.0 | 0.6 | |
| Earnings Yield | 2.1% | 9.4% | 3.0% | 3.3% | 1.8% | 1.4% | 2.1% | 2.2% | 7.2% | 8.4% | 8.6% | 17.6% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.74B | $1.65B | $1.57B | $1.55B | $1.53B | $1.41B | $1.39B | $1.35B | $1.37B | $1.33B | $1.01B | $1.24B | $1.28B | $1.22B | $430M | $1.32B | |
| Cost of Revenue | $392M | $363M | $343M | $345M | $344M | $302M | $292M | $263M | $276M | $287M | $141M | $251M | $257M | $330M | $-99M | $254M | |
| Gross Profit | $1.35B | $1.29B | $1.23B | $1.21B | $1.19B | $1.11B | $1.09B | $1.09B | $1.09B | $1.04B | $870M | $993M | $1.03B | $992M | $529M | $1.07B | |
| R&D Expense | $279M | $263M | $268M | $281M | $276M | $255M | $271M | $253M | $272M | $257M | $215M | $243M | $244M | $261M | $131M | $234M | |
| SG&A Expense | $561M | $522M | $603M | $515M | $502M | $466M | $492M | $421M | $448M | $428M | $354M | $382M | $410M | $436M | $201M | $377M | |
| Operating Income | $513M | $478M | $151M | $307M | $411M | $395M | $313M | $351M | $366M | $349M | $291M | $366M | $264M | $388M | $198M | $402M | |
| Interest Income | $30M | $34M | · | · | $37M | $36M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $17M | $72M | $3M | $3M | $-1M | $3M | $33M | $28M | $2M | $6M | $3M | $7M | $2M | $2M | $6M | $-2M | |
| Pretax Income | $520M | $459M | $90M | $348M | $400M | $434M | $390M | $403M | $384M | $371M | $311M | $388M | $275M | $399M | $211M | $407M | |
| Income Tax | $278M | $78M | $26M | $56M | $64M | $70M | $45M | $41M | $20M | $46M | $21M | $53M | $21M | $58M | $11M | $64M | |
| Net Income | $242M | $381M | $91M | $291M | $333M | $358M | $386M | $3.07B | $366M | $352M | $370M | $385M | $307M | $340M | $398M | $344M | |
| EPS (Basic) | $0.42 | $0.66 | $0.16 | $0.50 | $0.57 | $0.61 | $0.65 | $5.14 | $0.61 | $0.58 | $0.61 | $0.63 | $0.51 | $0.56 | $0.66 | $0.55 | |
| EPS (Diluted) | $0.42 | $0.66 | $0.16 | $0.50 | $0.56 | $0.61 | $0.65 | $5.13 | $0.61 | $0.58 | $0.61 | $0.63 | $0.50 | $0.56 | $0.65 | $0.55 | |
| Shares (Basic) | 576,400,000 | 579,200,000 | · | 584,700,000 | 587,000,000 | 586,900,000 | · | 597,200,000 | 602,100,000 | 601,600,000 | · | 607,000,000 | 606,900,000 | 607,500,000 | · | 619,800,000 | |
| Shares (Diluted) | 577,600,000 | 580,700,000 | · | 585,700,000 | 587,900,000 | 587,800,000 | · | 598,100,000 | 604,300,000 | 604,100,000 | · | 609,500,000 | 610,300,000 | 610,900,000 | · | 624,500,000 | |
| EBITDA | $513M | $518M | · | $307M | $411M | $431M | · | $351M | $369M | $426M | · | $418M | $327M | $424M | · | $402M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.91B | $2.45B | $2.94B | $2.69B | $3.27B | $3.14B | $3.05B | $3.68B | $1.64B | $1.22B | · | $1.41B | $1.04B | $872M | · | $1.25B | |
| Short-term Investments | $1.35B | $1.23B | $1.29B | $1.16B | $789M | $758M | $931M | $770M | $345M | $473M | · | $454M | $467M | $382M | · | $491M | |
| Receivables | $770M | $776M | $660M | $693M | $697M | $669M | $609M | $716M | $778M | $818M | · | $740M | $754M | $718M | · | $618M | |
| Inventory | $1.13B | $1.12B | $1.13B | $1.14B | $1.14B | $1.11B | $1.09B | $1.10B | $1.02B | $1.21B | · | $1.03B | $980M | $914M | · | $758M | |
| Prepaid Expense | $119M | $136M | $135M | $125M | $110M | $111M | $121M | $115M | $110M | $138M | · | $133M | $123M | $119M | · | $88M | |
| Other Current Assets | $360M | $330M | $339M | $323M | $314M | $304M | $348M | $231M | $252M | $251M | · | $236M | $217M | $190M | · | $268M | |
| Current Assets | $6.82B | $6.23B | $6.74B | $6.36B | $6.58B | $6.21B | $6.29B | $6.73B | $4.52B | $4.17B | · | $4.07B | $3.65B | $3.26B | · | $3.51B | |
| PP&E (Net) | $1.84B | $1.82B | $1.81B | $1.74B | $1.73B | $1.70B | $1.69B | $1.68B | $1.64B | $1.77B | · | $1.68B | $1.66B | $1.65B | · | $1.57B | |
| PP&E (Gross) | · | · | $2.66B | · | · | · | $2.48B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $850M | · | · | · | $794M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1.95B | $1.82B | $1.77B | $1.77B | $1.78B | $1.78B | $1.78B | $1.61B | $1.15B | $1.25B | $1.15B | $1.30B | $1.30B | $1.31B | $1.06B | $1.16B | |
| Intangibles | $1.38B | $1.23B | $1.13B | $1.13B | $1.17B | $1.17B | $1.18B | $956M | $417M | $447M | · | $430M | $431M | $447M | · | $266M | |
| Other Non-current Assets | $616M | $739M | $730M | $785M | $743M | $743M | $722M | $684M | $790M | $768M | · | $447M | $412M | $294M | · | $316M | |
| Total Assets | $13.87B | $13.32B | $13.70B | $13.27B | $13.49B | $13.02B | $13.06B | $12.97B | $10.10B | $9.74B | · | $9.37B | $9.00B | $8.65B | · | $8.64B | |
| Accounts Payable | $210M | $181M | $228M | $165M | $162M | $172M | $197M | $173M | $186M | $212M | · | $191M | $193M | $181M | · | $155M | |
| Current Liabilities | $1.51B | $1.41B | $1.81B | $1.59B | $1.40B | $1.39B | $1.51B | $1.94B | $1.22B | $1.11B | · | $1.24B | $1.16B | $1.08B | · | $918M | |
| Capital Leases | $82M | $80M | $83M | $75M | $79M | $78M | $79M | $85M | $74M | $77M | · | $70M | $64M | $66M | · | $67M | |
| Other Non-current Liabilities | $382M | $351M | $362M | $363M | $379M | $358M | $373M | $323M | $257M | $266M | · | $240M | $243M | $260M | · | $221M | |
| Total Liabilities | $3.14B | $2.99B | $3.36B | $3.07B | $2.88B | $2.83B | $2.99B | $3.36B | $2.59B | $2.55B | · | $2.64B | $2.56B | $2.59B | · | $2.42B | |
| Total Debt | $599M | $598M | · | $598M | $598M | $598M | · | $598M | $597M | $597M | · | $597M | $597M | $596M | · | $596M | |
| Common Stock | $662M | $660M | $659M | $658M | $658M | $656M | $655M | $654M | $654M | $652M | · | $650M | $649M | $647M | · | $646M | |
| Retained Earnings | $14.86B | $14.62B | $14.24B | $14.15B | $13.86B | $13.53B | $13.17B | $12.78B | $9.71B | $9.34B | · | $8.62B | $8.24B | $7.93B | · | $7.19B | |
| Treasury Stock | $7.67B | $7.51B | $7.09B | $7.05B | $6.46B | $6.45B | $6.19B | $6.09B | $5.18B | $5.02B | · | $4.58B | $4.40B | $4.39B | · | $3.28B | |
| AOCI | $-215M | $-221M | $-238M | $-250M | $-264M | $-254M | $-244M | $-252M | $-220M | $-233M | · | $-250M | $-256M | $-255M | · | $-256M | |
| Stockholders' Equity | $10.62B | $10.33B | $10.34B | $10.21B | $10.55B | $10.13B | $10.00B | $9.55B | $7.44B | $7.12B | · | $6.66B | $6.38B | $5.98B | · | $6.22B | |
| Liabilities + Equity | $13.87B | $13.32B | $13.70B | $13.27B | $13.49B | $13.02B | $13.06B | $12.97B | $10.10B | $9.74B | · | $9.37B | $9.00B | $8.65B | · | $8.64B | |
| Shares Outstanding | 576,600,000 | 577,000,000 | 580,700,000 | 580,700,000 | 587,900,000 | 586,200,000 | 588,600,000 | 589,800,000 | 602,300,000 | 602,400,000 | 650,500,000 | 606,500,000 | 607,900,000 | 606,000,000 | 646,300,000 | 619,400,000 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $43M | $41M | $43M | $39M | $38M | $37M | $43M | $34M | $40M | $38M | $37M | $37M | $36M | $35M | $35M | $35M | |
| Stock-based Comp | $42M | $45M | $39M | $41M | $38M | $40M | $32M | $42M | $44M | $45M | $30M | $33M | $37M | $39M | $28M | $30M | |
| Restructuring | · | · | $5M | $100.0K | · | · | $0 | $33M | · | · | · | $0 | · | · | · | · | |
| Other Non-cash | · | $-423M | · | · | · | $-154M | · | · | · | $-488M | · | · | · | · | · | · | |
| Operating Cash Flow | $652M | $44M | $451M | $574M | $290M | $280M | $-128M | $352M | $372M | $-54M | $137M | $412M | $34M | $314M | $283M | $310M | |
| CapEx | $67M | $65M | $97M | $58M | $49M | $56M | $50M | $52M | $85M | $65M | $88M | $55M | $48M | $62M | $69M | $60M | |
| Investing Cash Flow | $-193M | $-93M | $-198M | $-428M | $-172M | $85M | $-577M | $2.70B | $125M | $63M | $14M | $89M | $70M | $500.0K | $95M | $-202M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | $153M | $422M | $41M | $589M | $6M | $259M | $100M | $901M | $158M | $200.0K | $448M | $174M | $8M | $249M | $866M | $100M | |
| Net Stock Activity | · | $-422M | · | · | · | $-259M | · | · | · | $-200.0K | · | · | · | $-249M | · | · | |
| Financing Cash Flow | $-300.0K | $-451M | $-11M | $-740M | $53M | $-258M | $29M | $-977M | $-97M | $62M | $-413M | $-143M | $52M | $-207M | $-838M | $-70M | |
| Net Change in Cash | $462M | $-492M | $245M | $-595M | $141M | $90M | $-625M | $2.03B | $429M | $81M | $-266M | $366M | $171M | $104M | $-479M | $49M | |
| Free Cash Flow | · | $-21M | · | · | · | $224M | · | · | · | $-119M | · | · | · | $253M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 77.5% | 78.0% | · | 77.8% | 77.5% | 78.6% | · | 80.6% | 79.4% | 75.9% | · | 76.3% | 77.6% | 77.4% | · | 80.8% | |
| Operating Margin | 29.5% | 29.0% | · | 19.8% | 26.8% | 28.0% | · | 25.9% | 26.6% | 24.2% | · | 28.2% | 21.4% | 26.6% | · | 30.5% | |
| Net Margin | 13.9% | 23.1% | · | 18.7% | 21.8% | 25.3% | · | 226.7% | 26.4% | 22.0% | · | 26.0% | 20.1% | · | · | · | |
| Pretax Margin | 29.9% | 27.8% | · | 22.4% | 26.1% | 30.7% | · | 29.7% | 27.9% | 25.6% | · | 29.7% | 22.1% | 27.3% | · | 30.9% | |
| EBITDA Margin | 29.5% | 31.4% | · | 19.8% | 26.8% | 30.5% | · | 25.9% | 26.6% | 26.7% | · | 28.2% | 21.4% | 29.0% | · | 30.5% | |
| ROA | 1.8% | 2.9% | · | 2.2% | 2.8% | 3.1% | · | 27.5% | 3.8% | 3.8% | · | 4.3% | 3.5% | · | · | · | |
| ROE | 2.3% | 3.7% | · | 2.9% | 3.7% | 4.2% | · | 37.9% | 5.3% | 5.4% | · | 6.0% | 5.0% | · | · | · | |
| ROIC | 2.1% | 3.6% | · | 2.4% | 3.1% | 3.1% | · | 3.1% | 4.3% | 4.3% | · | 5.0% | 4.2% | 5.1% | · | 5.0% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 4.4 | · | 4.0 | 4.7 | 4.5 | · | 3.5 | 3.7 | 3.8 | · | 3.3 | 3.2 | 3.0 | · | 3.8 | |
| Quick Ratio | 3.3 | 3.2 | · | 2.9 | 3.4 | 3.3 | · | 2.7 | 2.3 | 2.3 | · | 2.1 | 2.0 | 1.8 | · | 2.6 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Receivables Turnover | 2.4 | 2.3 | · | 2.2 | 2.1 | 1.9 | · | 1.9 | 1.8 | 2.1 | · | 2.2 | 2.2 | 2.2 | · | 2.2 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $18.41 | $17.90 | · | $17.57 | $17.94 | $17.28 | · | $16.18 | $12.35 | $11.82 | · | $10.98 | $10.49 | $9.86 | · | $10.04 | |
| Revenue / Share | $3.01 | $2.84 | · | $2.65 | $2.61 | $2.40 | · | $2.26 | $2.29 | $2.65 | · | $2.43 | $2.51 | $2.39 | · | $2.11 | |
| Cash Flow / Share | · | $0.08 | · | · | · | $0.48 | · | · | · | $-0.09 | · | · | · | $0.51 | · | · | |
| Cash / Share | $5.04 | $4.24 | · | $4.62 | $5.57 | $5.36 | · | $6.23 | $2.73 | $2.03 | · | $2.33 | $1.72 | $1.44 | · | $2.01 | |
| EPS (TTM) | $1.74 | $1.88 | · | $2.32 | $6.95 | $7.00 | · | $6.93 | $2.43 | $2.32 | · | $2.34 | $2.26 | $2.41 | · | $2.31 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.51B | $6.30B | · | $5.88B | $5.69B | $5.52B | · | $5.07B | $4.95B | $4.86B | · | $4.17B | $4.25B | $4.34B | · | $5.36B | |
| Net Income TTM | $1.00B | $1.10B | · | $1.37B | $4.15B | $4.18B | · | $4.16B | $1.47B | $1.41B | · | $1.43B | $1.39B | $1.49B | · | · | |
| Market Cap | $52.16B | $46.21B | · | $45.16B | $45.98B | $42.49B | · | $38.92B | $55.63B | $57.57B | · | $42.02B | $57.34B | $50.13B | · | $51.18B | |
| Enterprise Value | $48.51B | $43.13B | · | $41.92B | $42.52B | $39.19B | · | $35.07B | $54.24B | $56.46B | · | $40.75B | $56.43B | $49.48B | · | $50.04B | |
| P/E | 52.0 | 42.6 | · | 33.5 | 11.3 | 10.4 | · | 9.5 | 38.0 | 41.2 | · | 29.6 | 41.7 | 34.3 | · | 35.8 | |
| P/S | 8.0 | 7.3 | · | 7.7 | 8.1 | 7.7 | · | 7.7 | 11.2 | 11.8 | · | 10.1 | 13.5 | 11.5 | · | 9.5 | |
| P/B | 4.9 | 4.5 | · | 4.4 | 4.4 | 4.2 | · | 4.1 | 7.5 | 8.1 | · | 6.3 | 9.0 | 8.4 | · | 8.2 | |
| P / Tangible Book | 7.2 | 6.3 | · | 6.2 | 6.1 | 5.9 | · | 5.6 | 9.5 | 10.6 | · | 8.5 | 12.3 | 11.9 | · | 10.7 | |
| P / Cash Flow | · | 1054.9 | · | · | · | 151.5 | · | · | · | -1076.0 | · | · | · | 159.6 | · | · | |
| EV / Revenue | 7.4 | 6.8 | · | 7.1 | 7.5 | 7.1 | · | 6.9 | 10.9 | 11.6 | · | 9.8 | 13.3 | 11.4 | · | 9.3 | |
| Earnings Yield | 1.9% | 2.4% | · | 3.0% | 8.9% | 9.7% | · | 10.5% | 2.6% | 2.4% | · | 3.4% | 2.4% | 2.9% | · | 2.8% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B |
| सकल मार्जिन % | 78.0% | 79.5% | 77.0% | 79.9% | 76.1% |
| परिचालन मार्जिन % | 20.8% | 25.4% | 25.6% | 32.5% | 32.3% |
| शुद्ध आय | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B |
| तनुकरणित EPS | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| वर्तमान अनुपात | 3.7 | 4.2 | 3.4 | 3.0 | 3.1 |
| त्वरित अनुपात | 2.7 | 3.0 | 2.0 | 1.8 | 2.0 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $1.33B | $290M | $643M | $974M | $1.41B |
संस्थागत मालिक (13F) 1432 फाइलर्स · $52.4B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
1432
धारित मूल्य
$52.4B
नई स्थितियाँ
155
बाहर निकली पोजीशन
97
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 155 (+6 पिछली तिमाही की तुलना में) | 97 (-12 पिछली तिमाही की तुलना में) | 471 (+23 पिछली तिमाही की तुलना में) | 469 (+12 पिछली तिमाही की तुलना में) | +13.8M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $5974271834 | 70079435 | 11.40% | शेयर |
| BlackRock, Inc. | $5318092039 | 58789433 | 10.15% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $3402739018 | 37615952 | 6.50% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2389175425 | 26411402 | 4.56% | शेयर |
| STATE STREET CORP | $2381082692 | 26321940 | 4.55% | शेयर |
| JPMORGAN CHASE & CO | $2077369996 | 22783175 | 3.97% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $1522257896 | 16827967 | 2.91% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $1390906696 | 15437251 | 2.66% | शेयर |
| Bank of New York Mellon Corp | $1274082304 | 14084483 | 2.43% | शेयर |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1176248067 | 13002965 | 2.25% | शेयर |
| Ninety One UK Ltd | $1116050276 | 12337502 | 2.13% | शेयर |
| Aristotle Capital Management, LLC | $783906442 | 8665712 | 1.50% | शेयर |
| FMR LLC | $763115873 | 8435949 | 1.46% | शेयर |
| NORGES BANK | $757492410 | 8373783 | 1.45% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $693526113 | 8660416 | 1.32% | शेयर |
| BROWN ADVISORY INC | $666327162 | 7365987 | 1.27% | शेयर |
| BANK OF AMERICA CORP /DE/ | $605396715 | 6692424 | 1.16% | शेयर |
| Artisan Partners Limited Partnership | $599361052 | 6625703 | 1.14% | शेयर |
| MORGAN STANLEY | $573459576 | 6339368 | 1.09% | शेयर |
| DEUTSCHE BANK AG\ | $516552291 | 5710284 | 0.99% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $513572538 | 5677344 | 0.98% | शेयर |
| NORTHERN TRUST CORP | $513019376 | 5671229 | 0.98% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $437088491 | 5458148 | 0.83% | शेयर |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | $434208000 | 4800000 | 0.83% | शेयर |
| GOLDMAN SACHS GROUP INC | $411512754 | 4549113 | 0.79% | शेयर |
| Legal & General Group Plc | $389088546 | 4301222 | 0.74% | शेयर |
| CITADEL ADVISORS LLC | $361652295 | 3997925 | 0.69% | शेयर |
| Invesco Ltd. | $359806234 | 3977518 | 0.69% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $334928288 | 3702299 | 0.64% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $334071856 | 3693034 | 0.64% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $324280556 | 3584795 | 0.62% | शेयर |
| ROYAL BANK OF CANADA | $316740000 | 3501447 | 0.60% | शेयर |
| PRIMECAP MANAGEMENT CO/CA/ | $308314004 | 3408291 | 0.59% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $292399738 | 3232365 | 0.56% | शेयर |
| Holocene Advisors, LP | $283979721 | 3139285 | 0.54% | शेयर |
| Nuveen, LLC | $267803860 | 2960468 | 0.51% | शेयर |
| NEUBERGER BERMAN GROUP LLC | $261237879 | 2886953 | 0.50% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $250776107 | 2772232 | 0.48% | शेयर |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $238277000 | 2634054 | 0.45% | शेयर |
| Amundi | $233363816 | 2579748 | 0.45% | शेयर |
| Mirova US LLC | $229802865 | 2540381 | 0.44% | शेयर |
| Allspring Global Investments Holdings, LLC | $228999539 | 2489396 | 0.44% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $219553940 | 2427083 | 0.42% | शेयर |
| UBS Group AG | $212640342 | 2350656 | 0.41% | शेयर |
| Russell Investments Group, Ltd. | $207120205 | 2288745 | 0.40% | शेयर |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $175696355 | 1942132 | 0.34% | शेयर |
| SEI INVESTMENTS CO | $171883685 | 1900137 | 0.33% | शेयर |
| Assenagon Asset Management S.A. | $163997286 | 1812926 | 0.31% | शेयर |
| Point72 Asset Management, L.P. | $160486895 | 1774120 | 0.31% | शेयर |
| NORDEA INVESTMENT MANAGEMENT AB | $147126018 | 1629844 | 0.28% | शेयर |
कार्यकर्ता और 5%+ मालिक 1 होल्डिंग
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| अघोषित रिपोर्टिंग व्यक्ति | 5 अप्रैल 2001 | · | प्रारंभिक फाइलिंग | बोर्ड अभियान | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 48 इनसाइडर्स · 20 अधिकारी · 8 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Bernard J Zovighian | CEO | 27 जुलाई 2026 S | 8916 | 0 | 8 | $-6996971 |
| Theodora Mistras | CVP, Chief Financial Officer | 9 जुलाई 2026 A | 99920 | 0 | 0 | $0 |
| Thomas M Abate | CVP, CFO | 14 मई 2013 A | 43047 | 0 | 0 | $0 |
| Wayne Markowitz | CVP, JAPAC | 14 सितमबर 2026 F | 19371 | 0 | 5 | $-1042352 |
| Andrew M. Dahl | SVP, Corporate Controller | 13 सितमबर 2026 F | 14615 | 0 | 2 | $-98430 |
| Daniel J. Lippis | CVP, TAVR | 11 सितमबर 2026 M | 40034 | 0 | 13 | $-871621 |
| Daveen Chopra | CVP, TMTT, Surgical & IHFM | 11 सितमबर 2026 F | 43926 | 0 | 4 | $-3190031 |
| Annette Bruls | CVP, EMEACLA | 28 अगस्त 2026 S | 17984 | 0 | 1 | $-237907 |
| Carlyn D Solomon | CVP, Critical Care & Vascular | 28 अक्टूबर 2014 M | 31154 | 0 | 0 | $0 |
| Christine Z Mccauley | CVP, Human Resources | 13 मई 2013 F | 4035 | 0 | 0 | $0 |
| Paul C Redmond | CVP, Global Operations | 13 मई 2013 S | 12534 | 0 | 0 | $0 |
| Bruce P Garren | CVP, Public Affairs/Special Co | 13 मई 2013 F | 56071 | 0 | 0 | $0 |
| John H Kehl JR | CVP, Strategy & Corp Dev | 7 मई 2013 F | 101767 | 0 | 0 | $0 |
| Robert C Reindl | CVP, H.R. and Communications | 27 जुलाई 2012 M | 1124 | 0 | 0 | $0 |
| Aimee S Weisner | CVP, General Counsel | 9 मई 2012 A | 1675 | 0 | 0 | $0 |
| Corinne H Nevinny | CVP & Pres., Global Ops | 13 मई 2010 A | 16687 | 0 | 0 | $0 |
| Anita Bessler | CVP | 31 अगस्त 2007 S | 29410 | 0 | 0 | $0 |
| John Alexander Martin | CVP, North America | 10 मई 2007 A | 15300 | 0 | 0 | $0 |
| Stuart L Foster | CVP, Critical Care / Vascular | 10 मई 2007 A | 24604 | 0 | 0 | $0 |
| Randel William Woodgrift | Corp VP, Manufacturing Ops | 4 अगस्त 2005 M | 3349 | 0 | 0 | $0 |
| John T Cardis | निदेशक | 10 अगस्त 2016 S | 91458 | 0 | 0 | $0 |
| Barbara J Mcneil | निदेशक | 4 फ़रवरी 2016 S | 46454 | 0 | 0 | $0 |
| Robert Alexander Ingram | निदेशक | 15 मई 2015 A | 32367 | 0 | 0 | $0 |
| Michael R Bowlin | निदेशक | 14 नवमबर 2014 M | 81751 | 0 | 0 | $0 |
| David E I Pyott | निदेशक | 9 मई 2014 A | 53582 | 0 | 0 | $0 |
| NEAL PHILIP M | निदेशक | 12 अगस्त 2008 M | 27333 | 0 | 0 | $0 |
| Vernon R Loucks JR | निदेशक | 9 मई 2008 A | 24133 | 0 | 0 | $0 |
| Donald E Bobo JR | · | 27 मई 2026 S | 98611 | 0 | 12 | $-11153294 |
| Scott B. Ullem | · | 11 मई 2026 M | 46740 | 0 | 7 | $-3875008 |
| Leslie C. Davis | · | 8 मई 2026 A | 9834 | 0 | 0 | $0 |
| Ramona Sequeira | · | 8 मई 2026 A | 6779 | 0 | 0 | $0 |
| David T Feinberg | · | 8 मई 2026 A | 9087 | 0 | 0 | $0 |
| Kieran Gallahue | · | 8 मई 2026 A | 4315 | 0 | 0 | $0 |
| Nicholas J Valeriani | · | 8 मई 2026 A | 84423 | 0 | 0 | $0 |
| Heisz Leslie Stone | · | 8 मई 2026 A | 34199 | 0 | 1 | $-218117 |
| Steven R Loranger | · | 8 मई 2026 A | 8997 | 0 | 0 | $0 |
| Paul A Laviolette | · | 8 मई 2026 A | 17552 | 0 | 0 | $0 |
| Larry L Wood | · | 18 अगस्त 2025 M | 206900 | 0 | 0 | $0 |
| Catherine M. Szyman | · | 3 सितमबर 2024 F | 81287 | 0 | 0 | $0 |
| Jean-Luc M Lemercier | · | 7 जुलाई 2024 F | 184686 | 0 | 0 | $0 |
| Robert W.A. Sellers | · | 11 मई 2024 F | 17081 | 0 | 0 | $0 |
| Michael A Mussallem | · | 2 मई 2024 M | 4486 | 0 | 0 | $0 |
| Martha H. Marsh | · | 12 मई 2023 A | 31880 | 0 | 0 | $0 |
| Huimin Wang | · | 8 जुलाई 2022 M | 99381 | 0 | 0 | $0 |
| William J Link PHD | · | 8 मई 2020 A | 11349 | 0 | 0 | $0 |
| Wesley W Von Schack | · | 1 अगस्त 2019 S | 8000 | 0 | 0 | $0 |
| Patrick B Verguet | · | 31 मई 2017 M | 129137 | 0 | 0 | $0 |
| Randall J Nelson | · | 30 सितमबर 2003 A | · | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 128 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IHI · iShares Trust | 4.43% | 1622151 SH | 11 सितमबर 2026 | दैनिक |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1.73% | 1827 NS | 31 जुलाई 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.64% | 165684 SH | 1 अक्टूबर 2026 | दैनिक |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.55% | 12485 NS | 31 जुलाई 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 1.14% | 4411246 SH | 19 अगस्त 2026 | दैनिक |
| CVAR · ETF Opportunities Trust | 0.90% | 4502 NS | 31 जुलाई 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0.81% | 22947 NS | 31 जुलाई 2026 | N-PORT |
| IYH · iShares Trust | 0.80% | 333769 SH | 11 सितमबर 2026 | दैनिक |
| NULV · Nushares ETF Trust | 0.78% | 199212 NS | 31 जुलाई 2026 | N-PORT |
| SDG · iShares Trust | 0.77% | 14866 SH | 11 सितमबर 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.77% | 1733147 SH | 19 अगस्त 2026 | दैनिक |
| NULC · Nushares ETF Trust | 0.75% | 6147 NS | 31 जुलाई 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.72% | 274258 NS | 31 जुलाई 2026 | N-PORT |
| IMCG · iShares Trust | 0.67% | 307122 SH | 11 सितमबर 2026 | दैनिक |
| IXJ · iShares Trust | 0.63% | 303150 SH | 11 सितमबर 2026 | दैनिक |
| JGLO · J.P. Morgan Exchange-Traded Fund Tr… | 0.58% | 451454 NS | 31 जुलाई 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.57% | 11330 NS | 31 जुलाई 2026 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0.55% | 4726 NS | 31 जुलाई 2026 | N-PORT |
| NULG · Nushares ETF Trust | 0.52% | 160328 NS | 31 जुलाई 2026 | N-PORT |
| SUSA · iShares Trust | 0.50% | 233488 SH | 11 सितमबर 2026 | दैनिक |
| VO · VANGUARD INDEX FUNDS | 0.50% | 12477902 SH | 19 अगस्त 2026 | दैनिक |
| IWS · iShares Trust | 0.49% | 851606 SH | 11 सितमबर 2026 | दैनिक |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0.38% | 204605 NS | 31 जुलाई 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.37% | 56826 NS | 31 जुलाई 2026 | N-PORT |
| IWR · iShares Trust | 0.36% | 2336086 SH | 11 सितमबर 2026 | दैनिक |
| EGUS · iShares Trust | 0.36% | 1132 SH | 11 सितमबर 2026 | दैनिक |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0.34% | 3899 NS | 31 जुलाई 2026 | N-PORT |
| IMCB · iShares Trust | 0.34% | 64965 SH | 11 सितमबर 2026 | दैनिक |
| EVUS · iShares Trust | 0.30% | 13166 SH | 11 सितमबर 2026 | दैनिक |
| FFLG · FIDELITY COVINGTON TRUST | 0.28% | 19459 NS | 31 जुलाई 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.28% | 154640 SH | 1 अक्टूबर 2026 | दैनिक |
| XOEF · iShares Trust | 0.28% | 720 SH | 11 सितमबर 2026 | दैनिक |
| ESUM · Strategy Shares | 0.27% | 5627 NS | 31 जुलाई 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0.24% | 31833 NS | 31 जुलाई 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0.24% | 188776 NS | 31 जुलाई 2026 | N-PORT |
| CATH · Global X Funds | 0.24% | 35583 NS | 31 जुलाई 2026 | N-PORT |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0.22% | 749 NS | 31 जुलाई 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.21% | 2272009 SH | 1 अक्टूबर 2026 | दैनिक |
| ESGU · iShares Trust | 0.20% | 421118 SH | 11 सितमबर 2026 | दैनिक |
| USXF · iShares Trust | 0.20% | 34234 SH | 11 सितमबर 2026 | दैनिक |
| SIZE · iShares Trust | 0.20% | 9721 SH | 11 सितमबर 2026 | दैनिक |
| EUSA · iShares, Inc. | 0.19% | 42285 SH | 11 सितमबर 2026 | दैनिक |
| VTV · VANGUARD INDEX FUNDS | 0.19% | 5470146 SH | 19 अगस्त 2026 | दैनिक |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.18% | 12350 NS | 31 जुलाई 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.18% | 327155 NS | 31 जुलाई 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.17% | 31155 NS | 31 जुलाई 2026 | N-PORT |
| CHRI · Global X Funds | 0.15% | 140 NS | 31 जुलाई 2026 | N-PORT |
| ILCG · iShares Trust | 0.15% | 53996 SH | 11 सितमबर 2026 | दैनिक |
| QUAL · iShares Trust | 0.15% | 807173 SH | 11 सितमबर 2026 | दैनिक |
| IQSU · New York Life Investments ETF Trust | 0.15% | 5623 NS | 31 जुलाई 2026 | N-PORT |
| SUSL · iShares Trust | 0.15% | 20323 SH | 11 सितमबर 2026 | दैनिक |
| ESLV · Strategy Shares | 0.14% | 236 NS | 31 जुलाई 2026 | N-PORT |
| DSI · iShares Trust | 0.14% | 87882 SH | 11 सितमबर 2026 | दैनिक |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.14% | 344148 SH | 19 अगस्त 2026 | दैनिक |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.14% | 4863000 | 1 अक्टूबर 2026 | दैनिक |
| ACWV · iShares, Inc. | 0.14% | 52593 SH | 11 सितमबर 2026 | दैनिक |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.14% | 172000 | 1 अक्टूबर 2026 | दैनिक |
| IWD · iShares Trust | 0.13% | 1266618 SH | 11 सितमबर 2026 | दैनिक |
| HAPI · Harbor ETF Trust | 0.13% | 7541 NS | 31 जुलाई 2026 | N-PORT |
| AQLT · iShares Trust | 0.12% | 4632 SH | 11 सितमबर 2026 | दैनिक |
| GLBL · Pacer Funds Trust | 0.12% | 15 NS | 31 जुलाई 2026 | N-PORT |
| EGLE · Global X Funds | 0.11% | 29 NS | 31 जुलाई 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.10% | 71482 SH | 19 अगस्त 2026 | दैनिक |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.10% | 19009 SH | 1 अक्टूबर 2026 | दैनिक |
| USCL · iShares Trust | 0.09% | 30549 SH | 11 सितमबर 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 8617 SH | 1 अक्टूबर 2026 | दैनिक |
| TOPC · iShares Trust | 0.09% | 349 SH | 11 सितमबर 2026 | दैनिक |
| IVE · iShares Trust | 0.09% | 515927 SH | 11 सितमबर 2026 | दैनिक |
| ESMV · iShares Trust | 0.09% | 81 SH | 11 सितमबर 2026 | दैनिक |
| LGDX · Tidal Trust III | 0.09% | 1493 NS | 31 जुलाई 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0.09% | 128864 SH | 19 अगस्त 2026 | दैनिक |
| ACVF · ETF Opportunities Trust | 0.09% | 1589 NS | 31 जुलाई 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.09% | 22900 NS | 31 जुलाई 2026 | N-PORT |
| XVV · iShares Trust | 0.09% | 6682 SH | 11 सितमबर 2026 | दैनिक |
| IUSV · iShares Trust | 0.09% | 271422 SH | 11 सितमबर 2026 | दैनिक |
| XRMI · Global X Funds | 0.08% | 475 NS | 31 जुलाई 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.08% | 14955304 SH | 19 अगस्त 2026 | दैनिक |
| VV · VANGUARD INDEX FUNDS | 0.08% | 672462 SH | 19 अगस्त 2026 | दैनिक |
| XYLG · Global X Funds | 0.08% | 591 NS | 31 जुलाई 2026 | N-PORT |
| XTR · Global X Funds | 0.08% | 44 NS | 31 जुलाई 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.08% | 29356 NS | 31 जुलाई 2026 | N-PORT |
| XYLD · Global X Funds | 0.08% | 28920 NS | 31 जुलाई 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.08% | 86729 SH | 1 अक्टूबर 2026 | दैनिक |
| PBP · Invesco Exchange-Traded Fund Trust | 0.08% | 3428 SH | 1 अक्टूबर 2026 | दैनिक |
| IVV · iShares Trust | 0.08% | 7257429 SH | 11 सितमबर 2026 | दैनिक |
| DFVX · Dimensional ETF Trust | 0.08% | 4635 NS | 31 जुलाई 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.08% | 99424 SH | 1 अक्टूबर 2026 | दैनिक |
| BKLC · BNY Mellon ETF Trust | 0.07% | 47622 NS | 31 जुलाई 2026 | N-PORT |
| XCLR · Global X Funds | 0.07% | 31 NS | 31 जुलाई 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 76534 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.07% | 106648 NS | 31 जुलाई 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0.07% | 9386 NS | 31 जुलाई 2026 | N-PORT |
| ILCB · iShares Trust | 0.07% | 10752 SH | 11 सितमबर 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.07% | 175602 NS | 31 जुलाई 2026 | N-PORT |
| IYY · iShares Trust | 0.07% | 24812 SH | 11 सितमबर 2026 | दैनिक |
| VOXP · Advisors Series Trust | 0.07% | 48 NS | 31 जुलाई 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.07% | 2173 NS | 31 जुलाई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.07% | 27431 NS | 31 जुलाई 2026 | N-PORT |
| IWB · iShares Trust | 0.07% | 393450 SH | 11 सितमबर 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.07% | 18282795 SH | 19 अगस्त 2026 | दैनिक |
| VOOG · VANGUARD ADMIRAL FUNDS | 0.07% | 197076 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.07% | 94564 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.07% | 48000 SH | 19 अगस्त 2026 | दैनिक |
| QDPL · Pacer Funds Trust | 0.07% | 13875 NS | 31 जुलाई 2026 | N-PORT |
| TOV · EA Series Trust | 0.07% | 2241 NS | 31 जुलाई 2026 | N-PORT |
| ITOT · iShares Trust | 0.07% | 752546 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.07% | 156590 SH | 11 सितमबर 2026 | दैनिक |
| DFAC · Dimensional ETF Trust | 0.07% | 365592 NS | 31 जुलाई 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.07% | 7283 SH | 1 अक्टूबर 2026 | दैनिक |
| IVW · iShares Trust | 0.06% | 564876 SH | 11 सितमबर 2026 | दैनिक |
| PHDG · Invesco Actively Managed Exchange-T… | 0.06% | 446 SH | 1 अक्टूबर 2026 | दैनिक |
| IUSG · iShares Trust | 0.06% | 232595 SH | 11 सितमबर 2026 | दैनिक |
| HCMT · Direxion Shares ETF Trust | 0.06% | 4008 NS | 31 जुलाई 2026 | N-PORT |
| TOK · iShares Trust | 0.06% | 1613 SH | 11 सितमबर 2026 | दैनिक |
| SPXL · Direxion Shares ETF Trust | 0.06% | 45012 NS | 31 जुलाई 2026 | N-PORT |
| URTH · iShares, Inc. | 0.06% | 52555 SH | 11 सितमबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.05% | 13604 NS | 31 जुलाई 2026 | N-PORT |
| ACWI · iShares Trust | 0.05% | 184834 SH | 11 सितमबर 2026 | दैनिक |
| ROUS · Lattice Strategies Trust | 0.04% | 3407 NS | 31 जुलाई 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.04% | 480405 SH | 19 अगस्त 2026 | दैनिक |
| CRBN · iShares Trust | 0.04% | 4703 SH | 11 सितमबर 2026 | दैनिक |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.03% | 37758 SH | 1 अक्टूबर 2026 | दैनिक |
| DXUV · Dimensional ETF Trust | 0.03% | 1805 NS | 31 जुलाई 2026 | N-PORT |
| PEVC · Pacer Funds Trust | 0.01% | 2 NS | 31 जुलाई 2026 | N-PORT |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 14 जुलाई 2026 | दैनिक |
EW विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 40 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$101.50
+19.2%
13 32.5%
मजबूत खरीद
18 45.0%
खरीदें
9 22.5%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
26 विश्लेषक · 2026-09-30माध्य लक्ष्य $100.96 +18.6%
अभी
वर्तमान मूल्य $85.15
निम्न$84.00
माध्य$100.96
उच्च$110.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | · | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
अभी कोई खुला सिग्नल नहीं — कोई कार्ड भरा नहीं है, और यह ईमानदार है।
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 4, 2026 को फाइल किया गया